{"id":825051,"date":"2025-03-12T16:49:24","date_gmt":"2025-03-12T20:49:24","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/"},"modified":"2025-03-12T16:49:24","modified_gmt":"2025-03-12T20:49:24","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/","title":{"rendered":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)"},"content":{"rendered":"
\n

BALA CYNWYD, Pa., March 12, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com<\/u><\/a>) or Marc Ackerman (mackerman@brodskysmith.com<\/u><\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n

\n Checkpoint Therapeutics, Inc. (Nasdaq – CKPT)<\/strong>\n <\/p>\n

Under the terms of the agreement, Checkpoint will be acquired by Sun Pharmaceutical Industries Limited for $4.10 per share in cash at closing and a contingent value right for up to $0.70 per share on achievement of a milestone. The investigation concerns whether the Checkpoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company\u2019s shareholders are receiving fair value for their shares.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/checkpoint-therapeutics-inc-nasdaq-ckpt\/<\/u><\/a>.<\/p>\n

\n Redfin Corporation (Nasdaq – RDFN)<\/strong>\n <\/p>\n

Under the terms of the agreement, Redfin will be acquired by Rocket Companies (NYSE – RKT). Each share of Redfin common stock will be exchanged for a fixed ratio of 0.7926 shares of Rocket Companies Class A common stock (a value of approximately $12.50 per share). Upon completion of the transaction, current Rocket Companies shareholders will own approximately 95% of the combined company on a fully diluted basis, while Redfin shareholders will own approximately 5%. The investigation concerns whether the Redfin Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/redfin-corporation-nasdaq-rdfn\/<\/u><\/a>.<\/p>\n

\n Amplify Energy Corp. (NYSE – AMPY)<\/strong>\n <\/p>\n

Under the terms of the Merger Agreement, Amplify will merge with Juniper Capital (\u201cJuniper\u201d). Amplify shareholders will retain approximately 61% of Amplify\u2019s outstanding equity and approximately 39% will be owned by Juniper. The investigation concerns whether the Amplify Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/amplify-energy-corp-nyse-ampy\/<\/u><\/a>.<\/p>\n

\n Blackboxstocks Inc. (Nasdaq – BLBX)<\/strong>\n <\/p>\n

Under the terms of the Merger Agreement, Blackboxstocks will be acquired by REalloys Inc. (\u201cREalloys\u201d). It is anticipated Blackbox\u2019s stockholders will own approximately 7.3% of the combined company\u2019s shares of common stock expected to be outstanding upon closing of the Merger. The investigation concerns whether the Blackboxstocks Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company\u2019s shareholders.<\/p>\n

Additional information can be found at https:\/\/www.brodskysmith.com\/cases\/blackboxstocks-inc-nasdaq-blbx\/<\/u><\/a>.<\/p>\n

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

BALA CYNWYD, Pa., March 12, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Checkpoint Therapeutics, Inc. (Nasdaq – CKPT) Under the terms of the agreement, Checkpoint will be acquired by Sun Pharmaceutical Industries Limited for $4.10 per share in cash at closing and a contingent value right for up to $0.70 per share on achievement of a milestone. The investigation concerns whether the Checkpoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company\u2019s shareholders are receiving fair … <\/p>\n

Continue reading “BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-825051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., March 12, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Checkpoint Therapeutics, Inc. (Nasdaq – CKPT) Under the terms of the agreement, Checkpoint will be acquired by Sun Pharmaceutical Industries Limited for $4.10 per share in cash at closing and a contingent value right for up to $0.70 per share on achievement of a milestone. The investigation concerns whether the Checkpoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company\u2019s shareholders are receiving fair … Continue reading "BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-12T20:49:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)\",\"datePublished\":\"2025-03-12T20:49:24+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/\"},\"wordCount\":518,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/\",\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=\",\"datePublished\":\"2025-03-12T20:49:24+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., March 12, 2025 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. Checkpoint Therapeutics, Inc. (Nasdaq – CKPT) Under the terms of the agreement, Checkpoint will be acquired by Sun Pharmaceutical Industries Limited for $4.10 per share in cash at closing and a contingent value right for up to $0.70 per share on achievement of a milestone. The investigation concerns whether the Checkpoint Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the Company\u2019s shareholders are receiving fair … Continue reading \"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-12T20:49:24+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)","datePublished":"2025-03-12T20:49:24+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/"},"wordCount":518,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/","name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq - CKPT), Redfin Corporation (Nasdaq - RDFN), Amplify Energy Corp. (NYSE - AMPY), Blackboxstocks Inc. (Nasdaq - BLBX) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=","datePublished":"2025-03-12T20:49:24+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5MzU2MSM2ODAzNTcwIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-checkpoint-therapeutics-inc-nasdaq-ckpt-redfin-corporation-nasdaq-rdfn-amplify-energy-corp-ny\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (Nasdaq – CKPT), Redfin Corporation (Nasdaq – RDFN), Amplify Energy Corp. (NYSE – AMPY), Blackboxstocks Inc. (Nasdaq – BLBX)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=825051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=825051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=825051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=825051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}